Could a simple drug tame the dangerous side effects of CAR-T cancer therapy?
Disease control
Not yet recruiting
This study tests whether giving the drug anakinra early can prevent severe cytokine release syndrome (CRS) in children and young adults with B-cell acute lymphoblastic leukemia (B-ALL) who are receiving CAR-T cell therapy. Participants receive anakinra at the first sign of fever,…
Phase: PHASE1, PHASE2 • Sponsor: Kevin McNerney • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC